Apolipoprotein E in synaptic plasticity and alzheimer’s disease: Potential cellular and molecular mechanisms

Molecules and Cells

Volumn 37, Issue 11, 2014, Pages 833-840

  Kim, Jaekwang ^a   Yoon, Hyejin ^a,b   Basak, Jacob ^c   Kim, Jungsu ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; ApoER2; Apolipoprotein E; HSPG; LRP1; Synaptic plasticity

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SYNDECAN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITION; DENDRITIC SPINE; HUMAN; IN VITRO STUDY; MICROTUBULE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; ANIMAL; BRAIN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEINS E; BRAIN; HUMANS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84983071309     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0248     Document Type: Review

References (96)

1. Bales, K.R., Verina, T., Dodel, R.C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E.M., Little, S.P., Cummins, D.J., et al. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263-264.
2. Basak, J.M., and Kim, J. (2010). Differential effects of ApoE isoforms on dendritic spines in vivo: linking an Alzheimer’s disease risk factor with synaptic alterations. J. Neurosci. 30, 4526-4527.
3. Bien-Ly, N., Gillespie, A.K., Walker, D., Yoon, S.Y., and Huang, Y. (2012). Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803-4811.
4. Bour, A., Grootendorst, J., Vogel, E., Kelche, C., Dodart, J.C., Bales, K., Moreau, P.H., Sullivan, P.M., and Mathis, C. (2008). Middleaged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav. Brain Res. 193, 174-182.
5. Bourne, J.N., and Harris, K.M. (2008). Balancing structure and function at hippocampal dendritic spines. Annu. Rev. Neurosci. 31, 47-67.
6. Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R.E., Wyss-Coray, T., Mucke, L., and Mahley, R.W. (1999). Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867-4880.
7. Cambon, K., Davies, H.A., and Stewart, M.G. (2000). Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience 97, 685-692.
8. Castellano, J.M., Kim, J., Stewart, F.R., Jiang, H., DeMattos, R.B., Patterson, B.W., Fagan, A.M., Morris, J.C., Mawuenyega, K.G., Cruchaga, C., et al. (2011). Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med. 3, 89ra57.
9. Chai, X., Forster, E., Zhao, S., Bock, H.H., and Frotscher, M. (2009). Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J. Neurosci. 29, 288-299.
10. Chang, S., ran Ma, T., Miranda, R.D., Balestra, M.E., Mahley, R.W., and Huang, Y. (2005). Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. USA 102, 18694-18699.
11. Chen, Y., Durakoglugil, M.S., Xian, X. and Herz, J. (2010). ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl. Acad. Sci. USA 107, 12011-12016.
12. Cingolani, L.A., and Goda, Y. (2008). Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat. Rev. Neurosci. 9, 344-356.
13. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921-923.
14. Cramer, P.E., Cirrito, J.R., Wesson, D.W., Lee, C.Y., Karlo, J.C., Zinn, A.E., Casali, B.T., Restivo, J.L., Goebel, W.D., James, M.J., et al. (2012). ApoE-directed therapeutics rapidly clear betaamyloid and reverse deficits in AD mouse models. Science 335, 1503-1506.
15. D’Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D.S., Sheldon, M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479.
16. DeMattos, R.B., Curtiss, L.K., and Williams, D.L. (1998). A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem. 273, 4206-4212.
17. Dietschy, J.M., and Turley, S.D. (2004). Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397.
18. Dumanis, S.B., Tesoriero, J.A., Babus, L.W., Nguyen, M.T., Trotter, J.H., Ladu, M.J., Weeber, E.J., Turner, R.S., Xu, B., Rebeck, G.W., et al. (2009). ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 29, 15317-15322.
19. Ethell, I.M., and Yamaguchi, Y. (1999). Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J. Cell Biol. 144, 575-586.
20. Ethell, I.M., Irie, F., Kalo, M.S., Couchman, J.R., Pasquale, E.B., and Yamaguchi, Y. (2001). EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31, 1001-1013.
21. Fagan, A.M., Bu, G., Sun, Y., Daugherty, A., and Holtzman, D.M. (1996). Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 30121-30125.
22. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N., and van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356.
23. Golde, T.E., Petrucelli, L., and Lewis, J. (2010). Targeting Abeta and tau in Alzheimer’s disease, an early interim report. Exp. Neurol. 223, 252-266.
24. Gordon, I., Grauer, E., Genis, I., Sehayek, E., and Michaelson, D.M. (1995). Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 1-4.
25. Grootendorst, J., Bour, A., Vogel, E., Kelche, C., Sullivan, P.M., Dodart, J.-C., Bales, K., and Mathis, C. (2005) Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav. Brain Res. 159, 1-14.
26. Gu, J., Firestein, B.L., and Zheng, J.Q. (2008). Microtubules in dendritic spine development. J. Neurosci. 28, 12120-12124.
27. Haass, C., and Selkoe, D.J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid betapeptide. Nat. Rev. Mol. Cell Biol. 8, 101-112.
28. Hartman, R.E., Wozniak, D.F., Nardi, A., Olney, J.W., Sartorius, L., and Holtzman, D.M. (2001). Behavioral phenotyping of GFAPApoE3 and -ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer’s-like neuropathology. Exp. Neurol. 170, 326-344.
29. Hoe, H.S., Freeman, J., and Rebeck, G.W. (2006). Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons. Mol. Neurodegener. 1, 18.
30. Holtzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G., and Schwartz, A.L. (1995). Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92, 9480-9484.
31. Hu, X., Viesselmann, C., Nam, S., Merriam, E., and Dent, E.W. (2008). Activity-dependent dynamic microtubule invasion of dendritic spines. J. Neurosci. 28, 13094-13105.
32. Hudry, E., Dashkoff, J., Roe, A.D., Takeda, S., Koffie, R.M., Hashimoto, T., Scheel, M., Spires-Jones, T., Arbel-Ornath, M., Betensky, R., et al. (2013). Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci. Transl. Med. 5, 212ra161.
33. Jaworski, J., Kapitein, L.C., Gouveia, S.M., Dortland, B.R., Wulf, P.S., Grigoriev, I., Camera, P., Spangler, S.A., Di Stefano, P., Demmers, J., et al. (2009). Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 61, 85-100.
34. Ji, Z.S., Pitas, R.E., and Mahley, R.W. (1998). Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. J. Biol. Chem. 273, 13452-13460.
35. Ji, Y., Gong, Y., Gan, W., Beach, T., Holtzman, D.M., and Wisniewski, T. (2003). Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer’s disease patients. Neuro Sci. 122, 305-315.
36. Jiang, Q., Lee, C.Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T.M., Collins, J.L., et al. (2008). ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693.
37. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D.W., Golde, T., and McGowan, E. (2007). Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633.
38. Kim, J., Basak, J.M., and Holtzman, D.M. (2009a). The role of apolipoprotein E in Alzheimer’s disease. Neuron 63, 287-303.
39. Kim, J., Castellano, J.M., Jiang, H., Basak, J.M., Parsadanian, M., Pham, V., Mason, S.M., Paul, S.M., and Holtzman, D.M. (2009b). Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A[beta] clearance. Neuron 64, 632-644.
40. Kim, J., Jiang, H., Park, S., Eltorai, A., Stewart, F., Yoon, H., Basak, J.M., Finn, M.B., and Holtzman, D.M. (2011). Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-beta amyloidosis. J. Neurosci. 31, 18007-18012.
41. Kim, J., Eltorai, A.E., Jiang, H., Liao, F., Verghese, P.B., Kim, J., Stewart, F.R., Basak, J.M., and Holtzman, D.M. (2012a). AntiapoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis. J. Exp. Med. 209, 2149-2156.
42. Kim, J., Yoon, H., Ramírez, C., Lee, S., Hoe, H., Fernández-Hernando, C., and Kim, J. (2012b). miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. Exp. Neurol. 235, 476-483.
43. Kinnunen, T., Raulo, E., Nolo, R., Maccarana, M., Lindahl, U., and Rauvala, H. (1996). Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J. Biol. Chem. 271, 2243-2248.
44. Kinnunen, T., Kaksonen, M., Saarinen, J., Kalkkinen, N., Peng, H.B., and Rauvala, H. (1998). Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273, 10702-10708.
45. Kitamura, H.W., Hamanaka, H., Watanabe, M., Wada, K., Yamazaki, C., Fujita, S.C., Manabe, T., and Nukina, N. (2004). Age-dependent enhancement of hippocampal long-term potentiation in knock-in mice expressing human apolipoprotein E4 instead of mouse apolipoprotein E. Neurosci. Lett. 369, 173-178.
46. Kornecook, T.J., McKinney, A.P., Ferguson, M.T., and Dodart, J.C. (2010). Isoform-specific effects of apolipoprotein E on cognitive performance in targeted-replacement mice overexpressing human APP. Genes Brain Behav. 9, 182-192.
47. Kowal, R.C., Herz, J., Weisgraber, K.H., Mahley, R.W., Brown, M.S., and Goldstein, J.L. (1990). Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265, 10771-10779.
48. Kramar, E.A., Chen, L.Y., Brandon, N.J., Rex, C.S., Liu, F., Gall, C.M., and Lynch, G. (2009). Cytoskeletal changes underlie estrogen’s acute effects on synaptic transmission and plasticity. J. Neurosci. 29, 12982-12993.
49. Kuszczyk, M.A., Sanchez, S., Pankiewicz, J., Kim, J., Duszczyk, M., Guridi, M., Asuni, A.A., Sullivan, P.M., Holtzman, D.M., and Sadowski, M.J. (2013). Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration. Am. J. Pathol. 182, 1750-1768.
50. Lane-Donovan, C., Philips, Gary T., and Herz, J. (2014). More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83, 771-787.
51. Lanz, T.A., Carter, D.B., and Merchant, K.M. (2003). Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246-253.
52. Liao, F., Hori, Y., Hudry, E., Bauer, A.Q., Jiang, H., Mahan, T.E., Lefton, K.B., Zhang, T.J., Dearborn, J.T., Kim, J., et al. (2014). Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis. J. Neurosci. 34, 7281-7292.
53. Libeu, C.P., Lund-Katz, S., Phillips, M.C., Wehrli, S., Hernaiz, M.J., Capila, I., Linhardt, R.J., Raffai, R.L., Newhouse, Y.M., Zhou, F., et al. (2001). New insights into the heparan sulfate proteoglycanbinding activity of apolipoprotein E. J. Biol. Chem. 276, 39138-39144.
54. Mahley, R.W., and Huang, Y. (2012). Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron 76, 871-885.
55. Mak, A.C., Pullinger, C.R., Tang, L.F., Wong, J.S., Deo, R.C., Schwarz, J.M., Gugliucci, A., Movsesyan, I., Ishida, B.Y., Chu, C., et al. (2014). Effects of the absence of apolipoprotein E on lipoproteins, neurocognitive function, and retinal runction. JAMA Neurol. (in press).
56. Mann, K.M., Thorngate, F.E., Katoh-Fukui, Y., Hamanaka, H., Williams, D.L., Fujita, S., and Lamb, B.T. (2004). Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model. Hum. Mol. Genet. 13, 1959-1968.
57. Masliah, E., Samuel, W., Veinbergs, I., Mallory, M., Mante, M., and Saitoh, T. (1997). Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751, 307-314.
58. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M.P., Beard, J., Das, P., et al. (2005). Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199.
59. Minami, S.S., Cordova, A., Cirrito, J.R., Tesoriero, J.A., Babus, L.W., Davis, G.C., Dakshanamurthy, S., Turner, R.S., Pak, D.T., Rebeck, G.W., et al. (2010). ApoE mimetic peptide decreases Abeta production in vitro and in vivo. Mol. Neurodegener. 5, 16.
60. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
61. Narita, M., Bu, G., Holtzman, D.M., and Schwartz, A.L. (1997). The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 68, 587-595.
62. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., and Pitas, R.E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
63. Nathan, B.P., Jiang, Y., Wong, G.K., Shen, F., Brewer, G.J., and Struble, R.G. (2002). Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 928, 96-105.
64. Nichol, K., Deeny, S.P., Seif, J., Camaclang, K., and Cotman, C.W. (2009). Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 5, 287-294.
65. Niu, S., Yabut, O., and D’Arcangelo, G. (2008). The reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J. Neurosci. 28, 10339-10348.
66. Osherovich, L. (2009). The APOE4 conundrum. SciBX 2, 1-3.
67. Pankiewicz, J.E., Guridi, M., Kim, J., Asuni, A.A., Sanchez, S., Sullivan, P.M., Holtzman, D.M., and Sadowski, M.J. (2014). Blocking the apoE/Abeta interaction ameliorates Abeta-related pathology in APOE2 and 4 targeted replacement Alzheimer model mice. Acta Neuropathol. Commun. 2, 75.
68. Penzes, P., and Jones, K.A. (2008). Dendritic spine dynamics--a key role for kalirin-7. Trends Neurosci. 31, 419-427.
69. Puttfarcken, P.S., Manelli, A.M., Falduto, M.T., Getz, G.S., and LaDu, M.J. (1997). Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures. J. Neurochem. 68, 760-769.
70. Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R.E., Mahley, R.W., and Mucke, L. (1998). Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95, 10914-10919.
71. Raber, J., Wong, D., Yu, G.Q., Buttini, M., Mahley, R.W., Pitas, R.E., and Mucke, L. (2000). Apolipoprotein E and cognitive performance. Nature 404, 352-354.
72. Ramaswamy, G., Xu, Q., Huang, Y., and Weisgraber, K.H. (2005). Effect of domain interaction on apolipoprotein E levels in mouse brain. J. Neurosci. 25, 10658-10663.
73. Rex, C.S., Gavin, C.F., Rubio, M.D., Kramar, E.A., Chen, L.Y., Jia, Y., Huganir, R.L., Muzyczka, N., Gall, C.M., and Miller, C.A. (2010). Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation. Neuron 67, 603-617.
74. Riddell, D.R., Zhou, H., Atchison, K., Warwick, H.K., Atkinson, P.J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008). Impact of Apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28, 11445-11453.
75. Ruiz, J., Kouiavskaia, D., Migliorini, M., Robinson, S., Saenko, E.L., Gorlatova, N., Li, D., Lawrence, D., Hyman, B.T., Weisgraber, K.H., et al. (2005). The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J. Lipid Res. 46, 1721-1731.
76. Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J.A., Li, Y., Schmidt, S.D., Mathews, P.M., Fryer, J.D., Holtzman, D.M., Sigurdsson, E.M., et al. (2004). A synthetic peptide blocking the Apolipoprotein E/{beta}-amyloid binding mitigates {beta}-amyloid toxicity and fibril formation in vitro and reduces {beta}-amyloid plaques in transgenic mice. Am. J. Pathol. 165, 937-948.
77. Sadowski, M.J., Pankiewicz, J., Scholtzova, H., Mehta, P.D., Prelli, F., Quartermain, D., and Wisniewski, T. (2006). Blocking the apolipoprotein E/amyloid-{beta} interaction as a potential therapeutic approach for Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 103, 18787-18792.
78. Selkoe, D.J. (2002). Alzheimer’s disease is a synaptic failure. Science 298, 789-791.
79. Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J., and Sabatini, B.L. (2007). Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875.
80. Shi, Y., Mantuano, E., Inoue, G., Campana, W.M., and Gonias, S.L. (2009). Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci. Signal. 2, ra18.
81. Siegel, J.A., Haley, G.E., and Raber, J. (2012). Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiol. Aging 33, 345-358.
82. Stanford, K.I., Bishop, J.R., Foley, E.M., Gonzales, J.C., Niesman, I.R., Witztum, J.L., and Esko, J.D. (2009). Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J. Clin. Invest. 119, 3236-3245.
83. Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D., and Roses, A.D. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
84. Sun, Y., Wu, S., Bu, G., Onifade, M.K., Patel, S.N., LaDu, M.J., Fagan, A.M., and Holtzman, D.M. (1998). Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocytespecific expression and differing biological effects of astrocytesecreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18, 3261-3272.
85. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A. and Katzman, R. (1991). Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
86. Teter, B., Xu, P.T., Gilbert, J.R., Roses, A.D., Galasko, D., and Cole, G.M. (1999). Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J. Neurochem. 73, 2613-2616.
87. Teter, B., Xu, P.T., Gilbert, J.R., Roses, A.D., Galasko, D., and Cole, G.M. (2002). Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J. Neurosci. Res. 68, 331-336.
88. Trommer, B.L., Shah, C., Yun, S.H., Gamkrelidze, G., Pasternak, E.S., Ye, G.L., Sotak, M., Sullivan, P.M., Pasternak, J.F., and LaDu, M.J. (2004). ApoE isoform affects LTP in human targeted replacement mice. Neuroreport 15, 2655-2658.
89. Trommer, B.L., Shah, C., Yun, S.H., Gamkrelidze, G., Pasternak, E.S., Stine, W.B., Manelli, A., Sullivan, P., Pasternak, J.F., and LaDu, M.J. (2005). ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol. Dis. 18, 75-82.
90. Veinbergs, I., Mallory, M., Mante, M., Rockenstein, E., Gilbert, J.R., and Masliah, E. (1999). Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neurosci. Lett. 265, 218-222.
91. Vitek, M.P., Brown, C.M., and Colton, C.A. (2007). APOE genotypespecific differences in the innate immune response. Neurobiol. Aging 30, 1350-1360.
92. Wahrle, S.E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., Jain, S., Hirsch-Reinshagen, V., Wellington, C.L., Bales, K.R., et al. (2008). Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118, 671-682.
93. Walsh, D.M., and Selkoe, D.J. (2004). Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 44, 181-193.
94. Wang, C., Wilson, W.A., Moore, S.D., Mace, B.E., Maeda, N., Schmechel, D.E., and Sullivan, P.M. (2005). Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol. Dis. 18, 390-398.
95. White, F., Nicoll, J.A., Roses, A.D., and Horsburgh, K. (2001). Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol. Dis. 8, 611-625.
96. Wilsie, L.C., Gonzales, A.M., and Orlando, R.A. (2006). Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, nonclathrin-mediated pathway. Lipids Health Dis. 5, 23.